Stay updated with breaking news from Import Alert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The regulator noted that visual inspectors manipulated particle and other defect counts on records to keep the finished product batches within rejection limits
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
B&K Securities airs concerns considering Cipla’s significant exposure to the US market, constituting 28% of consolidated sales
Stock Market Today - Cipla's Pithampur manufacturing facility receives warning letter. The facility remains important as exports of respiratory products such as Albuterol generics to the US are made form this facility.
The Federal Kratom Consumer Protection Act (KCPA) was introduced in October, amid a fairly steady pace of enforcement actions against kratom products that the Food and Drug Administration considers to be “adulterated” or unlawful.